- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05232526
Imagery in Early Stages of Dementia
The Effectiveness of Mental Imagery in Motor and Cognitive Rehabilitation in Subjects of Early Stage of Dementia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dementia is a disorder that is characterized by a decline in cognition involving one or more cognitive domains (learning and memory, language, executive function, complex attention, perceptual-motor, social cognition). The most common form of dementia in older adults is Alzheimer disease (AD), accounting for 60 to 80 percent of cases.
Mental imagery (MI) is a technique which involves envisioning motor actions without actual execution. MI is considered an effective rehabilitative tool in athletes, Parkinson's disease, and post stroke because it engages the same or similar neural systems as the actual execution of motor actions to improve gait, gait-related, and cognitive functions having as a result improvements in gait speed, stride length, tandem stance, timed up and go, clock drawing and stroop interference.
The recruitment of the population will be carried out by Day Care Centers in Athens Alzheimer Association. A group of elderly patients with early stage of dementia, aged 65 to 95 years, will participate. Information sheet and consent form will be provided to all participants. A randomized intervention study is designed to assess the efficacy of MI as therapeutic strategy for subjects with early stage of dementia and the sample will be randomized to one of the three following study groups: 1. MI and exercise program (intervention group) 2. Only exercise program (control group) 3. Neither MI nor exercise program (2nd control group). Assessment will be obtained in three-time periods: prior to the program, middle of the program and after the program.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna Christakou, PhD
- Phone Number: +306977370284
- Email: achristakou@uniwa.gr
Study Contact Backup
- Name: Vasiliki Sakellari, Pr
- Phone Number: +306979033952
- Email: vsakellari@uniwa.gr
Study Locations
-
-
Aigaleo
-
Athens, Aigaleo, Greece, 12243
- Recruiting
- University of West Attica
-
Contact:
- Anna Christakou, PhD
- Phone Number: +306977370284
- Email: achristakou@uniwa.gr
-
Contact:
- Vasiliki Sakellari, Pr
- Phone Number: +306979033952
- Email: vsakellari@uniwa.gr
-
Sub-Investigator:
- Christina Mpouzineki
-
Principal Investigator:
- Anna Christakou, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 95 years<age>65 years
- Diagnosed early stage of dementia
- Good oral and written speech and to perform orders
- Both sexes
- Ambulatory
- No other health issues in the last month
Exclusion Criteria:
- Late stage of dementia
- Psychiatric problems
- Serious health problems
- Not able to walk
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mental imagery (MI) and exercise program
MI will start immediately when the sample is going to start the exercise program.
The intervention group will undergo 24 sessions of imagery, starting from the 1st exercise program session.
Participants of the intervention group will undergo a 45-minute imagery session sitting in a quiet place after the end of every exercise program session.
The content of every imagery session is alike with the content of the exercise program session.
That means that every session includes imagery of the same exercises of the exercise program performed earlier by the subject in the Day Center.
Sessions are identical for all subjects of the intervention group.
The total duration of the physiotherapy exercise program will be 24 sessions, 2 times/week, duration of 45 minutes each session, 3 months (12 weeks).
|
Mental imagery and exercise program will be used to improve balance, functional status, cognitive ability, depression and quality of life of the sample
Questionnaires and functional tests are going to be used to evaluate balance, functional status, cognitive ability, depression and quality of life of the sample.
|
|
Placebo Comparator: Exercise program
The total duration of the physiotherapy exercise program will be 24 sessions, 2 times/week, duration of 45 minutes each session, 3 months (12 weeks).
|
Mental imagery and exercise program will be used to improve balance, functional status, cognitive ability, depression and quality of life of the sample
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change is being assessed (Change from Baseline Balance at 12 weeks)
Time Frame: Prior to the 1st week of the program, the 12th week of the program
|
The Berg Balance Scale (BBS) is used to objectively determine a subject's ability to safely balance during a series of predetermined tasks.
It is a 14 item list with each item consisting of a 5-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.
|
Prior to the 1st week of the program, the 12th week of the program
|
|
Change is being assessed (Change from Baseline Stability at 12 weeks)
Time Frame: Prior to the 1st week of the program, the 12th week of the program
|
The Multidirectional Reach Test (Reach in Four Directions Test) is a screening tool to determine the limits of stability of subjects in 4 directions: forward, backward, leftward and rightward.
Subjects performed maximal outstretched arm reach in each direction with their feet flat on the floor.
|
Prior to the 1st week of the program, the 12th week of the program
|
|
Change is being assessed (Change from Baseline Siti-to-stand ability at 12weeks)
Time Frame: Prior to the 1st week of the program, the 12th week of the program
|
The Five Times Sit-to-Stand Test (FTSST) is considered to be a useful, consistent and low-cost tool to assess sit-to-stand ability.
The FTSST measures the time taken to stand five times from a sitting position as quickly as possible that measures of lower limb strength, balance control and exercise capacity.
|
Prior to the 1st week of the program, the 12th week of the program
|
|
Change is being assessed (Change from Baseline Functional status at 12 weeks)
Time Frame: Prior to the 1st week of the program, the 12th week of the program
|
The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility.
It measures the time that a subject takes to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees.
|
Prior to the 1st week of the program, the 12th week of the program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive ability
Time Frame: Prior to the 1st week of the program, the 6th week of the program, the 12th week of the program
|
The Walking While Talking Test (WWITT) is a dual-task measure to examine cognitive-motor interactions.
During the WWTT, subjects walk at self-paced speed for 6 meters before turning and walking back to the starting point.
During the walking subjects recite 12 Greek alphabet letters (each letter at each step) starting with "A" (ΑΒΓΔ, ΚΛΜΝ, ΠΡΣΤ) until the starting point.
Time and errors in the alphabet will be recorded.
|
Prior to the 1st week of the program, the 6th week of the program, the 12th week of the program
|
|
Depression
Time Frame: Prior to the 1st week of the program, the 6th week of the program, the 12th week of the program
|
The Short-Form of Geriatric Depression Scale (SF-GDS) is a 15-question screening tool for depression in older adults, using a "Yes/No" format.
It takes 5-7 minutes to complete and is filled out by the researcher with minimal training in its use.
|
Prior to the 1st week of the program, the 6th week of the program, the 12th week of the program
|
|
Quality of life
Time Frame: Prior to the 6th week of the program, the 6th week of the program, the 12th week of the program
|
The Euro-Qol 5 Dimensions 5 Level of severity scale (Euro-Qol 5D-5L scale) is a preference-based Health Related Quality of Life measure which includes 5 domains, i.e., mobility, self-care, usual activities, pain/discomfort, anxiety/depression.
The core of all domains ranges from 1 (best score) up to 5 (worse score).
The total perceived quality of life will be graded by the patient.
Also it includes a Visual Analog Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).
|
Prior to the 6th week of the program, the 6th week of the program, the 12th week of the program
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 93292 - 26/10/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia of Alzheimer Type
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompleted
-
Chase Pharmaceuticals Corporation, an affiliate...CompletedDementia of Alzheimer's TypeUnited States
-
Charite University, Berlin, GermanyWithdrawnDementia of Type AlzheimerGermany
-
University of RostockDZNE, German Center for Neurodegenerative Disorders, GermanyUnknownDementia of the Alzheimer TypeGermany
-
Tianjin Anding HospitalRecruitingBPSD | Amisulpride | Olanzapine | Dementia of the Alzheimer TypeChina
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Dementia, Alzheimer Type | Dementia Alzheimers | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Dementia, MildUnited States
-
University of California, Los AngelesNational Institute on Aging (NIA)Enrolling by invitationAlzheimer Disease | Dementia Alzheimers | Dementia of Alzheimer TypeUnited States
-
Douglas Mental Health University InstituteMcGill University; Weston Brain InstituteCompletedMild Cognitive Impairment Due to Alzheimer Disease | Age-related Cognitive Decline | Dementia of the Alzheimer TypeCanada
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on Mental imagery (MI) and exercise program
-
Ohio UniversityNational Institute on Aging (NIA); University of Florida; Holzer Health SystemCompleted
-
Mateo Riera MarcoCompletedHealthy Volunteers | Muscle StrengthSpain
-
Istanbul University - Cerrahpasa (IUC)Not yet recruiting
-
Richard L. Roudebush VA Medical CenterVA Connecticut Healthcare SystemNot yet recruiting
-
Riphah International UniversityRecruitingVestibular HypofunctionPakistan
-
Medipol UniversityEnrolling by invitationPerformance Improvement in Beginner ArchersTurkey
-
McGill UniversityCompleted
-
October 6 UniversityCompletedMechanical Neck PainEgypt
-
Nova Southeastern UniversityCompletedPost Traumatic Stress Disorder PTSDUnited States